BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11322266)

  • 21. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
    Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ
    J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Zidovudine plus didanosine in HIV infected asymptomatic patients previously treated with zidovudine].
    López-Martínez C; Guarner J; Magis-Rodríguez C; Uribe-Zúñiga P; del Río-Chiriboga C
    Rev Invest Clin; 1998; 50(4):335-9. PubMed ID: 9830323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures.
    Johnson M; Grinsztejn B; Rodriguez C; Coco J; DeJesus E; Lazzarin A; Lichtenstein K; Wirtz V; Rightmire A; Odeshoo L; McLaren C
    AIDS; 2006 Mar; 20(5):711-8. PubMed ID: 16514301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Didanosine as a capsule. A reliable drug in a new dosage form].
    Jablonowski H
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():92-5. PubMed ID: 11373794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zidovudine plus didanosine in primary HIV-1 infection.
    Perrin L; Yerly S; Charvier A; Figueras G; Schockmel GA; Hirschel B
    Antivir Ther; 1997 Jan; 2(1):5-11. PubMed ID: 11322267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-retroviral therapy of HIV-infection. With preliminary results of the Swiss postmarketing surveillance of zidovudine].
    Jost J; Lüthy R
    Schweiz Med Wochenschr; 1991 Apr; 121(16):555-65. PubMed ID: 1904164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.
    Eron JJ; Feinberg J; Kessler HA; Horowitz HW; Witt MD; Carpio FF; Wheeler DA; Ruane P; Mildvan D; Yangco BG; Bertz R; Bernstein B; King MS; Sun E
    J Infect Dis; 2004 Jan; 189(2):265-72. PubMed ID: 14722892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of a once-daily regimen of lopinavir/ritonavir in HIV-1-infected children.
    van der Lee M; Verweel G; de Groot R; Burger D
    Antivir Ther; 2006; 11(4):439-45. PubMed ID: 16856617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric treatment update.
    Grubman S
    GMHC Treat Issues; 1996 Mar; 10(3):7-9. PubMed ID: 11363392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine.
    Kelleher T; Cross A; Dunkle L
    Clin Ther; 1999 Jul; 21(7):1182-92. PubMed ID: 10463516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
    Reliquet V; Ferré V; Hascoet C; Besnier JM; Bellein V; Arvieux C; Molina JM; Breux JP; Zucman D; Rozenbaum W; Allavena C; Raffi F;
    Antivir Ther; 1999; 4 Suppl 3():83-4. PubMed ID: 16021876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors.
    Englund JA; Raskino C; Vavro C; Palumbo P; Ross LL; McKinney R; Nikolic-Djokic D; Colgrove RC; Baker CJ;
    Pediatr Infect Dis J; 2004 Jan; 23(1):15-22. PubMed ID: 14743040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HAART with didanosine once versus twice daily: adherence and efficacy.
    Roca B; Lapuebla C; Vidal-Tegedor B
    Int J Infect Dis; 2005 Jul; 9(4):195-200. PubMed ID: 15964537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
    Podzamczer D; Ferrer E; Consiglio E; Gatell JM; Perez P; Perez JL; Luna E; González A; Pedrol E; Lozano L; Ocaña I; Llibre JM; Casiró A; Aranda M; Barrufet P; Martínez-Lacasa J; Miró JM; Badía X; Casado A; Lupo S; Cahn P; Maños M; Estela J
    Antivir Ther; 2002 Jun; 7(2):81-90. PubMed ID: 12212928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic potential of chloroquine added to zidovudine plus didanosine for HIV-1 infected children.
    Engchanil C; Kosalaraksa P; Lumbiganon P; Lulitanond V; Pongjunyakul P; Thuennadee R; Tungsawad S; Suwan-apichon O
    J Med Assoc Thai; 2006 Aug; 89(8):1229-36. PubMed ID: 17048434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
    Moolasart P; Likanonsakul S
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):280-7. PubMed ID: 12236426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pancreatic disease in patients with HIV treated with didanosine (DDI)].
    Ortega González E; Martín Herrera A; López de Medrano V; de Lelis FP; Ronda Gasulla FA; Gil Egea M; Ballester Belda E; Herrera Ballester A
    Rev Esp Enferm Dig; 1996 Feb; 88(2):114-7. PubMed ID: 8664067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection.
    Husson RN; Mueller BU; Farley M; Woods L; Kovacs A; Goldsmith JC; Ono J; Lewis LL; Balis FM; Brouwers P
    Pediatrics; 1994 Feb; 93(2):316-22. PubMed ID: 7907174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.